Steven Cohen’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.17M Buy
1,458,907
+972,023
+200% +$2.98M ﹤0.01% 1930
2026
Q2
$1.48M Sell
486,884
-178,405
-27% -$533K ﹤0.01% 2583
2026
Q1
$2.05M Buy
+665,289
New +$2.82M ﹤0.01% 2287
2025
Q4
– Sell
-476,926
Closed -$1.8M – 3886
2025
Q3
$1.8M Buy
+476,926
New +$1.84M ﹤0.01% 1483
2024
Q2
– Sell
-7,600
Closed -$77.4K – 1822
2024
Q1
$77.4K Sell
7,600
-1,238,900
-99% -$12.6M ﹤0.01% 2032
2023
Q4
$14M Buy
+1,246,500
New +$5.2M 0.03% 566
2023
Q2
– Sell
-13,987
Closed -$59K – 2133
2023
Q1
$59K Buy
+13,987
New +$166K ﹤0.01% 1750
2022
Q3
– Sell
-609,100
Closed -$7.13M – 1385
2022
Q2
$7.13M Buy
+609,100
New +$3.76M 0.03% 607
2021
Q3
– Sell
-1,564,654
Closed -$15.4M – 1021
2021
Q2
$15.4M Buy
+1,564,654
New +$21.4M 0.07% 346

Other funds holding ALT

Steven Cohen's ALT Position: Q3 2026 in Review

Steven Cohen increased its Altimmune (ALT) stake by 200% in Q3 2026, buying an estimated $2.98M and bringing the position to 1,458,907 shares worth $4.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1930.

Steven Cohen first reported a position in ALT in Q2 2021 and has held it in 9 quarters since. The position peaked at $15.4M in Q2 2021. 190 funds tracked by Wall St. Rank hold ALT as of Q3 2026.

  • Steven Cohen held 1,458,907 shares of Altimmune worth $4.17M as of Q3 2026.
  • Steven Cohen bought 972,023 Altimmune shares in Q3 2026, an estimated $2.98M.
  • Altimmune made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #1930 holding.
  • Steven Cohen first reported a position in Altimmune in Q2 2021 and has held it in 9 quarters since.
  • Steven Cohen's Altimmune position peaked at $15.4M in Q2 2021.
  • 190 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.